| [1] |
Siegel RL, Miller KD, Jemal A. Cancer Statistics，2019[J]. CA Cancer J Clin, 2019, 69(1):7-34.
|
| [2] |
Hundal R, Shaffer EA. Gallbaldder cancer: epidemiology and outcome[J]. Clin Epidemiol, 2014(6):99-109.
|
| [3] |
Kim YJ, Kim K. Conditional survival in patients with gallbladder cancer[J]. Clin J Cancer, 2017, 36(1):85.
|
| [4] |
Henley SJ, Weir HK, Jim MA，et al. Gallbladder cancer incidence and mortality United States 1999-2011[J]. Cancer Epidemiol Biomarkers Prev, 2015, 24(9):1319-1326.
|
| [5] |
Kumar R, Srinivasan R, Gupta N, et al. Spectrum of gallbladder malignancies on fine-needle aspiration cytology：5 years retrospective single institutional study with emphasis on uncommon variants[J]. Diagn Cytopathol, 2017, 45(1):36-42.
|
| [6] |
Berger-Richardson D, Chesney TR, Englesakis M, et al. Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: a systematic review[J]. Surgery, 2017, 161(3): 618-627.
|
| [7] |
Kim SH, Jung D, Ahn JH, et al. Differentiation between gallbladder cancer with acute cholecystitis: considerations for surgeons during emergency cholecystectomy, a cohort study[J]. Int J Surg, 2017(45):1-7.
|
| [8] |
Truant S, Chater C, Pruvot FR. Greatly enlarged thickened gallbladder. diagnosis: xanthogranulomatous cholecystitis (XGC)[J]. JAMA Surg, 2015, 150(3):267-268.
|
| [9] |
Lee ES, Kim JH, Joo I, et al. Xanthogranulomatous cholecystitis: diagnostic performance of US, CT, and MRI for differentiation from gallbladder cancer[J]. Abdom Imaging, 2015, 40(7):2281-2292.
|
| [10] |
Rajaguru K, Mehrotra S, Lalwani S, et al. New scoring system for differentiating xanthogranulomatous cholecystitis from gallbladder carcinoma: a tertiary care centre experience[J]. ANZ J Surg, 2018, 88(1/2):E34-39.
|
| [11] |
Muszynska C, Lundgren L, Lindell G, et al. Predictors of incidental gallbladder cancer in patients undergoing cholecystectomy for benign gallbladder disease: results from a population-based gallstone surgery registry[J]. Surgery, 2017, 162(2):256-263.
|
| [12] |
Tatli F, Ozgönül A, Yucel Y, et al. Incidental gallbladder cancer at cholecystectomy[J]. Ann Ital Chir, 2017(6):399-402.
|
| [13] |
Navarro Rosenblatt D, Durán Agüero S. Gallbladder cancer and nutritional risk factors in Chile[J]. Nutr Hosp, 2016, 33(1):105-110.
|
| [14] |
Kopf H, Schima W, Meng S. Differential diagnosis of gallbladder abnormalities: ultrasound, computed tomography, and magnetic resonance imaging[J]. Radiologe, 2019, 59(4):328-337.
|
| [15] |
Zhang HP, Bai M, Gu JY, et al. Value of contrast-enhanced ultrasound in the differential diagnosis of gallbladder lesion[J]. World J Gastroenterol, 2018, 24(6):744-751.
|
| [16] |
Corwin MT, Khera SS, Loehfelm TW, et al. Incidentally detected focal fundal gallbladder wall thickening at contrast-enhanced computed tomography: prevalence and computed tomography features of malignancy[J]. J Comput Assist Tomogr, 2019, 43(1): 149-154.
|
| [17] |
Ma KW, Cheung TT, She WH, et al. Diagnosis and prognostic role of 18-FDG PET/CT in the management of resectable biliary tract cancer[J]. World J Surg, 2018, 42(3):823-834.
|
| [18] |
Annunziata S, Pizzuto DA, Caldarella C, et al. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: a meta-analysis[J]. World J Surg, 2015, 21(40): 11481-11488.
|
| [19] |
Søreide K, Guest RV, Harrison EM, et al. Systematic review of management of incidental gallbladder cancer after cholecystectomy[J]. Br J Surg, 2019, 106(1):32-45.
|
| [20] |
Sharma A, Sharma KL, Gupta A, et al. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update[J]. World J Surg, 2017, 23(22):3978-3998.
|